Abstract: A method of expanding and maintaining human embryonic stem cells (ESCs) in an undifferentiated state by culturing the ESCs in a suspension culture under culturing conditions devoid of substrate adherence is provided. Also provided are a method of deriving ESC lines in the suspension culture and methods of generating lineage-specific cells from ESCs which were expanded in the suspension culture of the present invention.
Type:
Application
Filed:
November 16, 2017
Publication date:
March 8, 2018
Applicant:
Technion Research & Development Foundation Limited
Abstract: A new class of paromomycin-derived aminoglycosides, which exhibit efficient stop-codon mutation suppression activity, low toxicity and high selectivity towards eukaryotic cells are provided. Also provided are chemical and chemo-enzymatic processes of preparing these paromomycin-derived aminoglycosides and intermediates thereof, as well as pharmaceutical compositions containing the same, and uses thereof in the treatment of genetic disorders.
Type:
Application
Filed:
November 20, 2017
Publication date:
March 8, 2018
Applicant:
Technion Research & Development Foundation Limited
Inventors:
Timor BAASOV, Tamar BEN-YOSEF, Igor NUDELMAN, Annie REBIBO-SABBAH, Dalia SHALLOM-SHEZIFI, Mariana HAINRICHSON
Abstract: A method for managing communication among a plurality of social network members. The method comprises defining a multi participant task, setting at least one forward rule limiting the distribution an invitation message for participating in the multi participant task, forwarding the invitation message to at least one addressee from a plurality of social network members, allowing the at least one addressee to forward the invitation message to at least one additional addressee from the plurality of social network members under the at least one forward rule, monitoring a plurality of feedbacks to the invitation message to determine whether the multi participant task is achieved, and updating a status of the multi participant task according to the determination.
Type:
Grant
Filed:
March 29, 2016
Date of Patent:
February 27, 2018
Assignee:
Technion Research & Development Foundation Limited
Abstract: A method for reducing disk read rate by managing dataset mapping of virtual machine (VM) guest memory, comprising: monitoring a plurality of disk read write operations of a VM guest; updating a dataset mapping between disk blocks allocated to the VM guest and corresponding physical addresses of memory pages of the VM guest containing replica of data stored in the disk blocks, based on the plurality of disk read write operations; when identifying writing to one of the memory pages, removing a mapping of corresponding disk block and corresponding physical address of memory page; when reclaiming a mapped memory page of the VM guest by a host of the VM guest, discarding data contained in the memory page; and when the data is requested by the VM guest after it was reclaimed by said host, retrieving the data from corresponding disk block according to the mapping.
Type:
Application
Filed:
October 3, 2017
Publication date:
February 15, 2018
Applicant:
Technion Research & Development Foundation Limited
Inventors:
Assaf SCHUSTER, Nadav AMIT, Dan TSAFRIR
Abstract: The present invention provides a system including: a protein having a domain that binds a membranal component; an inlet for sample flow, an Isotachophoresis (ITP) system and a flow generating means connected or coupled to the aqueous parts of the ITP. The invention also provides a method for detecting and or sorting cells with this system.
Type:
Grant
Filed:
November 28, 2014
Date of Patent:
February 6, 2018
Assignee:
Technion Research and Development Foundation Limited
Abstract: A device images radiation from a scene. A detector is sensitive to the radiation in a first wavelength band. A lens forms an image of the scene on the detector. A filtering arrangement includes two sets of radiation absorbing molecules. A control unit switches the filtering arrangement between two states. In the first state, all of the radiation in the first wavelength band is transmitted to the detector. In the second state, the radiation in a second wavelength band within the first wavelength band is absorbed by the radiation absorbing molecules. The control unit synchronizes the switching of the filtering arrangement with the detector. Each pixel of the image formed on the detector includes two signals. The first signal includes information from the scene radiation in the first wavelength hand. The second signal excludes information from the scene radiation absorbed by the filtering arrangement in the second wavelength band.
Type:
Grant
Filed:
February 27, 2017
Date of Patent:
January 30, 2018
Assignees:
CI SYSTEMS ISRAEL LTD, TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD.
Inventors:
Karni Wolowelsky, Carmel Rotschild, Dario Cabib, Amir Gil
Abstract: Methods and systems that remove impurities from phosphogypsum (PG), including from radium and heavy metal salts, and produce gypsum binders and products. In one embodiment, PG is reacted with a chloride solution in an acidic environment under mechanical manipulation and/or heat followed by galvanic and/or zeolite absorption removal of impurities.
Type:
Grant
Filed:
April 2, 2015
Date of Patent:
January 16, 2018
Assignees:
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD., VANDERBILT UNIVERSITY
Inventors:
Konstantin Kovler, Boris Dashevsky, David Samuel Kosson, Yonathan Reches
Abstract: The present invention provides a composition including a poly-l-lactic acid (PLLA) and polylactic-co-glycolic-acid (PLGA) scaffold on which neuronal tissue is grown ex-vivo. Furthermore, the invention provides a method for making ex-vivo cellular vasculature networks, and a method for treating a neuronal injury in a subject by implanting the current composition.
Type:
Grant
Filed:
February 25, 2013
Date of Patent:
January 9, 2018
Assignee:
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD.
Abstract: A method of treating a bacterial infection in a subject is disclosed. The method comprises administering to the subject a therapeutically effective amount of a peptide being between 3 and 5 amino acids, wherein at least one amino acid of the 3 and 5 amino acids is selected from the group consisting of tryptophan, cysteine, proline and methionine.
Type:
Application
Filed:
September 7, 2017
Publication date:
January 4, 2018
Applicant:
Technion Research & Development Foundation Limited
Inventors:
Noam ADIR, Sharon NAVON, Tali SCHWARTZMAN
Abstract: The present invention concerns VLPT immunoreactive compositions for E. chaffeensis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. chaffeensis VLPT are disclosed.
Abstract: A method of expanding and maintaining human embryonic stem cells (ESCs) in an undifferentiated state by culturing the ESCs in a suspension culture under culturing conditions devoid of substrate adherence is provided. Also provided are a method of deriving ESC lines in the suspension culture and methods of generating lineage-specific cells from ESCs which were expanded in the suspension culture of the present invention.
Type:
Grant
Filed:
May 25, 2015
Date of Patent:
December 5, 2017
Assignee:
Technion Research & Development Foundation Limited
Abstract: Provided are methods of isolating pericyte progenitor cells from pluripotent stem cells such as embryonic stem cells and induced pluripotent stem cells, by isolating CD105+, CD73+ and/or CD105+/CD73+ cells from embryoid bodies and optionally by enriching the cells with CD31? cells. Also provided are methods of isolating endothelial cells and co-derivation of pericyte and endothelial cells progenitor cells from embryoid bodies, and methods of differentiating same for various therapeutic applications. In addition, the invention provides an isolated pericyte progenitor cell having an expression marker signature of CD105+/CD73+CD31?/alpha SMA?/CD133?/Flk-1?.
Type:
Application
Filed:
July 24, 2017
Publication date:
November 30, 2017
Applicant:
Technion Research & Development Foundation Limited
Inventors:
Ayelet DAR-OAKNIN, Joseph ITSKOVITZ-ELDOR
Abstract: The present invention provides HIV-derived lentivectors which are safe, highly efficient, and very potent for expressing transgenes for human gene therapy, especially, in human hematopoietic progenitor cells as well as in all other blood cell derivatives. The lentiviral vectors comprise a self-inactivating configuration for biosafety and promoters such as the EF1? promoter as one example. Additional promoters are also described. The vectors can also comprise additional transcription enhancing elements such as the wood chuck hepatitis virus post-transcriptional regulatory element. These vectors therefore provide useful tools for genetic treatments such as inherited and acquired lympho-hematological disorders, gene-therapies for cancers especially the hematological cancers, as well as for the study of hematopoiesis via lentivector-mediated modification of human HSCs.
Abstract: A new class of paromomycin-derived aminoglycosides, which exhibit efficient stop-codon mutation suppression activity, low toxicity and high selectivity towards eukaryotic cells are provided. Also provided are chemical and chemo-enzymatic processes of preparing these paromomycin-derived aminoglycosides and intermediates thereof, as well as pharmaceutical compositions containing the same, and uses thereof in the treatment of genetic disorders.
Type:
Grant
Filed:
June 14, 2015
Date of Patent:
November 21, 2017
Assignee:
Technion Research & Development Foundation Limited
Inventors:
Timor Baasov, Tamar Ben-Yosef, Igor Nudelman, Annie Rebibo-Sabbah, Dalia Shallom-Shezifi, Mariana Hainrichson
Abstract: Computerized, audio-based caricature exaggeration which includes: receiving a three-dimensional model of an object; receiving an audio sequence; generating a video frame sequence, said generating comprising computing a caricature of the object, wherein (a) the computing is with a different exaggeration factor for each of multiple ones of the video frames, and (b) the different exaggeration factor is based on one or more parameters of the audio sequence; and synthesizing the audio sequence and the video frame sequence into an audiovisual clip.
Type:
Grant
Filed:
April 7, 2015
Date of Patent:
November 14, 2017
Assignee:
Technion Research and Development Foundation Limited
Inventors:
Matan Sela, Yonathan Aflalo, Ron Kimmel
Abstract: The present invention concerns gp19 immunoreactive compositions for E. canis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. canis gp19 are disclosed.
Type:
Grant
Filed:
February 27, 2017
Date of Patent:
November 14, 2017
Assignee:
Research Development Foundation
Inventors:
Jere W. McBride, Christopher Kuyler Doyle
Abstract: A method for reducing disk read rate by managing dataset mapping of virtual machine (VM) guest memory, comprising: monitoring a plurality of disk read write operations of a VM guest; updating a dataset mapping between disk blocks allocated to the VM guest and corresponding physical addresses of memory pages of the VM guest containing replica of data stored in the disk blocks, based on the plurality of disk read write operations; when identifying writing to one of the memory pages, removing a mapping of corresponding disk block and corresponding physical address of memory page; when reclaiming a mapped memory page of the VM guest by a host of the VM guest, discarding data contained in the memory page; and when the data is requested by the VM guest after it was reclaimed by said host, retrieving the data from corresponding disk block according to the mapping.
Type:
Grant
Filed:
February 16, 2015
Date of Patent:
November 7, 2017
Assignee:
Technion Research & Development Foundation Limited
Inventors:
Assaf Schuster, Nadav Amit, Dan Tsafrir
Abstract: A novel method to reduce B-cell lymphoma cell migration to and engraftment of the spleen in patients with JAM-C positive B-cell lymphomas is described. In certain aspects, a method for identifying and treating JAM-C positive B-cell lymphoma patients with anti-JAM-C antibodies is provided. Recombinant antibody molecules that specifically bind to JAM-C are also disclosed.
Type:
Grant
Filed:
October 24, 2013
Date of Patent:
October 31, 2017
Assignee:
Research Development Foundation
Inventors:
Beat Imhof, Christiane Ody, Thomas Matthes, Carmen Donate